Try for free

Y51.6 ICD-10-CA code: alpha-Adrenoreceptor antagonists, not elsewhere classified, causing adverse effect in therapeutic use

Y51.6 is the ICD-10-CA code for “alpha-Adrenoreceptor antagonists, not elsewhere classified, causing adverse effect in therapeutic use” in CIHI’s FY 2026–2027 release, in effect from Apr 1, 2026.

Official description

Y51.6

alpha-Adrenoreceptor antagonists, not elsewhere classified, causing adverse effect in therapeutic use

Short description: Alp adrenrcp antgnst NEC adv eff Rx use

ICD-10-CA · Canada · Also written Y516

Notes for Y51.6

As CIHI prints them, with any note Y51.6 takes from the headings above it.

Includes

  • Complications of medical devicescorrect drug properly administered in therapeutic or prophylactic dosage as the cause of any adverse effectmisadventures to patients during surgical and medical caresurgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedureFrom Y40-Y84 Complications of medical and surgical care

Excludes

Conditions classified elsewhere.

Note

  • For list of specific drugs classified under the fourth-character subdivisions, see Table of drugs and chemicals in Alphabetical Index.From Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
  • This chapter, which in previous revisions of ICD constituted a supplementary classification, permits the classification of environmental events and circumstances as the cause of injury, poisoning and other adverse effects. Where a code from this section is applicable, it is intended that it shall be used in addition to a code from another chapter of the Classification indicating the nature of the condition. Most often, the condition will be classifiable to Chapter XIX, Injury, poisoning and certain other consequences of external causes (S00-T98). Causes of death should preferably be tabulated according to both Chapter XIX and Chapter XX, but if only one code is tabulated then the code from Chapter XX should be used in preference. Other conditions that may be stated to be due to external causes are classified in Chapters I to XVIII. For these conditions, codes from Chapter XX should be used to provide additional information for multiple-condition analysis only.From Chapter 20: External causes of morbidity and mortality (V01-Y98)

Where Y51.6 sits

  1. 1ChapterChapter 20: External causes of morbidity and mortality (V01-Y98)
  2. 2Block Y40-Y84Complications of medical and surgical care
  3. 3Block Y40-Y59Drugs, medicaments and biological substances causing adverse effects in therapeutic use
  4. 4Category Y51Drugs primarily affecting the autonomic nervous system
  5. 5Valid code Y51.6alpha-Adrenoreceptor antagonists, not elsewhere classified, causing adverse effect in therapeutic use

Source and release

Data release
ICD-10-CA · FY 2026–2027
Effective date
Apr 1, 2026
Publisher
CIHI

This page is built from the ICD-10-CA catalog that Vero Codes reads when it suggests codes: Canadian Institute for Health Information’s FY 2026–2027 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

See Y51.6 in the CIHI source

Frequently asked questions

What does ICD-10-CA code Y51.6 mean?

Y51.6 is the ICD-10-CA code for “alpha-Adrenoreceptor antagonists, not elsewhere classified, causing adverse effect in therapeutic use” in CIHI’s ICD-10-CA FY 2026–2027 release.

Where is Y51.6 in ICD-10-CA?

Y51.6 sits under Y51 Drugs primarily affecting the autonomic nervous system, within Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use, within Y40-Y84 Complications of medical and surgical care, within Chapter 20: External causes of morbidity and mortality (V01-Y98).

What coding notes apply to Y51.6?

ICD-10-CA lists Excludes, Note, Includes notes for Y51.6, including those from the headings it sits under. They are listed on this page with where each one comes from.

Which ICD-10-CA release does this page use?

It uses CIHI’s FY 2026–2027 release, in effect from Apr 1, 2026 to Mar 31, 2027. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.

Codes beside Y51.6

Y51.0Anticholinesterase agents causing adverse effect in therapeutic useY51.1Other parasympathomimetics [cholinergics] causing adverse effect in therapeutic useY51.2Ganglionic blocking drugs, not elsewhere classified, causing adverse effect in therapeutic useY51.3Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified, causing adverse effect in therapeutic useY51.4Predominantly alpha-adrenoreceptor agonists, not elsewhere classified, causing adverse effect in therapeutic useY51.5Predominantly beta-adrenoreceptor agonists, not elsewhere classified, causing adverse effect in therapeutic useY51.7beta-Adrenoreceptor antagonists, not elsewhere classified, causing adverse effect in therapeutic useY51.8Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified, causing adverse effect in therapeutic useY51.9Other and unspecified drugs primarily affecting the autonomic nervous system causing adverse effect in therapeutic use